Señales en vivo de OSSD.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:21):

Stats
Volumen de hoy	170 714
Volumen promedio	256 734
Capitalización de mercado	954.11M
EPS	SEK-0.500 ( 2023-11-21 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-13
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-6.42
ATR14	SEK0.0480 (0.47%)

Volumen Correlación

Largo: 0.11 (neutral)

Corto: 0.48 (neutral)

Signal:(47.205) Neutral

OssDsign AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OssDsign AB (publ) Correlación - Moneda/Commodity

0.90
( strong )

0.81
( strong )

0.00
( neutral )

0.83
( strong )

-0.76
( moderate negative )

OssDsign AB (publ) Finanzas

Annual	2023
Ingresos:	SEK112.16M
Beneficio Bruto:	SEK83.65M (74.58 %)
EPS:	SEK-1.600

FY	2023
Ingresos:	SEK112.16M
Beneficio Bruto:	SEK83.65M (74.58 %)
EPS:	SEK-1.600

FY	2022
Ingresos:	SEK56.99M
Beneficio Bruto:	SEK45.13M (79.20 %)
EPS:	SEK-1.700

FY	2021
Ingresos:	SEK31.73M
Beneficio Bruto:	SEK20.84M (65.70 %)
EPS:	SEK-0.895

Financial Reports:

No articles found.

OssDsign AB (publ)

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.